Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology - KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions

被引：0
|
作者：
Kirova, Youlia M. [1 ,2 ]
Loap, Pierre [1 ]
机构：
[1] Inst Curie, Dept Radiat Oncol, Paris, France
[2] Univ Versailles St Quentin, Fac Med, Versailles St Quentin, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
dermal growth factor receptor 2 (HER2) - positive tumors; LAPATINIB PLUS CAPECITABINE;
D O I：
10.1016/j.ijrobp.2024.01.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1402 / 1403
页数：2
相关论文
共 50 条
  • [1] Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+Breast Cancer With Brain Metastases: NRG Oncology - KROG/ RTOG 1119 Phase 2 Randomized Trial
    Kim, In Ah
    Winter, Kathryn A.
    Sperduto, Paul W.
    De Los Santos, Jennifer F.
    Peereboom, David M.
    Ogunleye, Tomi
    Boulter, Daniel
    Fritz, Joel M.
    Cho, Kwan Ho
    Shin, Kyung Hwan
    Zoberi, Imran
    Choi, Serah
    Palmer, Joshua D.
    Liem, Ben
    Kim, Yong Bae
    Anderson, Bethany M.
    Thakrar, Anupama W.
    Muanza, Thierry M.
    Kim, Michelle M.
    Choi, Doo Ho
    Mehta, Minesh P.
    White, Julia R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1391 - 1401
  • [2] NRG Oncology/RTOG 1119: PHASE II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery with Concurrent Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer - A Collaborative Study of NRG and KROG (NCT01622868)
    Kim, I. A.
    Moughan, J.
    Sperduto, P. W.
    De Los Santos, J. F.
    Peereboom, D.
    Ogunleye, T. B.
    Boulter, D.
    Cho, K. H.
    Shin, K. H.
    Zoberi, I.
    Choi, S.
    Palmer, J. D.
    Liem, B.
    Kim, Y. B.
    Anderson, B. M.
    Thakrar, A.
    Muanz, T. M.
    Choi, D. H.
    Kim, M. M.
    Mehta, M. P.
    White, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S175
  • [3] NRG ONCOLOGY/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY/STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER
    Kim, In Ah
    Winter, Kathryn
    Sperduto, Paul
    De Los Santos, Jennifer
    Peereboom, David
    Ogunleye, Tomi
    Boulter, Daniel
    Cho, Kwan Ho
    Shin, Kyung Hwan
    Zoberi, Imran
    Choi, Serah
    Palmer, Joshua
    Liem, Ben
    Kim, Yong Bae
    Anderson, Bethany
    Thakrar, Anupama
    Muanza, Thierry
    Kim, Michelle
    Choi, Doo Ho
    White, Julia
    Mehta, Minesh
    NEURO-ONCOLOGY, 2020, 22 : 42 - 42
  • [4] NRG oncology/RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain met from HER2-positive breast cancer - A collaborative study of RTOG and KROG (NCT01622868)
    White, J. R.
    Moughan, J.
    Kim, I. A.
    Peereboom, D. M.
    De Los Santos, J. F.
    Sperduto, P. W.
    Mehta, M. P.
    CANCER RESEARCH, 2016, 76
  • [5] NRG oncology/RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain met from HER2-positive breast cancer - A collaborative study of RTOG & KROG (NCT01622868)
    White, J. R.
    Moughan, J.
    Kim, I. A.
    Peereboom, D. M.
    De los Santos, J. F.
    Sperduto, P. W.
    Mehta, M. P.
    CANCER RESEARCH, 2017, 77
  • [6] NRG/RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM Her2-POSITIVE BREAST CANCER: A COLLABORATIVE STUDY OF NRG AND KROG (NCT01622868)
    Peereboom, David M.
    Moughan, Jennifer
    Kim, In Ah
    Delossantos, Jennifer F.
    Sperduto, Paul W.
    White, Julia R.
    Mehta, Minesh P.
    NEURO-ONCOLOGY, 2016, 18 : 10 - 10
  • [7] Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions
    Azim, Hamdy A.
    Azim, Hatem A., Jr.
    FUTURE ONCOLOGY, 2012, 8 (02) : 135 - 144
  • [8] TOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain metastasis from HER2-positive breast cancer-A collaborative study of RTOG and KROG (NCT01622868)
    Peereboom, David M.
    Winter, Kathryn A.
    Kim, In Ah
    De Los Santos, Jennifer F.
    Sperduto, Paul W.
    White, Julia R.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] GOOD RESULTS OF INTENSIVE SYSTEMIC TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
    Niwinska, Anna
    Murawska, Magdalema
    BREAST, 2013, 22 : S40 - S40
  • [10] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Rupert Bartsch
    Anna Sophie Berghoff
    Julia Furtner
    Maximilian Marhold
    Elisabeth Sophie Bergen
    Sophie Roider-Schur
    Angelika Martina Starzer
    Heidrun Forstner
    Beate Rottenmanner
    Karin Dieckmann
    Zsuzsanna Bago-Horvath
    Helmuth Haslacher
    Georg Widhalm
    Aysegül Ilhan-Mutlu
    Christoph Minichsdorfer
    Thorsten Fuereder
    Thomas Szekeres
    Leopold Oehler
    Birgit Gruenberger
    Christian F. Singer
    Ansgar Weltermann
    Rainer Puhr
    Matthias Preusser
    Nature Medicine, 2022, 28 : 1840 - 1847
12345